Literature DB >> 19105972

Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes.

Diederik H R Kempen1, Michael J Yaszemski, Andras Heijink, Theresa E Hefferan, Laura B Creemers, Jason Britson, Avudaiappan Maran, Kelly L Classic, Wouter J A Dhert, Lichun Lu.   

Abstract

Non-invasive imaging can provide essential information for the optimization of new drug delivery-based bone regeneration strategies to repair damaged or impaired bone tissue. This study investigates the applicability of nuclear medicine and radiological techniques to monitor growth factor retention profiles and subsequent effects on bone formation. Recombinant human bone morphogenetic protein-2 (BMP-2, 6.5 microg/scaffold) was incorporated into a sustained release vehicle consisting of poly(lactic-co-glycolic acid) microspheres embedded in a poly(propylene fumarate) scaffold surrounded by a gelatin hydrogel and implanted subcutaneously and in 5-mm segmental femoral defects in 9 rats for a period of 56 days. To determine the pharmacokinetic profile, BMP-2 was radiolabeled with (125)I and the local retention of (125)I-BMP-2 was measured by single photon emission computed tomography (SPECT), scintillation probes and ex vivo scintillation analysis. Bone formation was monitored by micro-computed tomography (microCT). The scaffolds released BMP-2 in a sustained fashion over the 56-day implantation period. A good correlation between the SPECT and scintillation probe measurements was found and there were no significant differences between the non-invasive and ex-vivo counting method after 8 weeks of follow up. SPECT analysis of the total body and thyroid counts showed a limited accumulation of (125)I within the body. Ectopic bone formation was induced in the scaffolds and the femur defects healed completely. In vivo microCT imaging detected the first signs of bone formation at days 14 and 28 for the orthotopic and ectopic implants, respectively, and provided a detailed profile of the bone formation rate. Overall, this study clearly demonstrates the benefit of applying non-invasive techniques in drug delivery-based bone regeneration strategies by providing detailed and reliable profiles of the growth factor retention and bone formation at different implantation sites in a limited number of animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19105972      PMCID: PMC3974410          DOI: 10.1016/j.jconrel.2008.11.023

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  30 in total

1.  Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model.

Authors:  H Uludag; D D'Augusta; J Golden; J Li; G Timony; R Riedel; J M Wozney
Journal:  J Biomed Mater Res       Date:  2000-05

2.  Biological activity of rhBMP-2 released from PLGA microspheres.

Authors:  J B Oldham; L Lu; X Zhu; B D Porter; T E Hefferan; D R Larson; B L Currier; A G Mikos; M J Yaszemski
Journal:  J Biomech Eng       Date:  2000-06       Impact factor: 2.097

3.  Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel.

Authors:  M Yamamoto; Y Tabata; L Hong; S Miyamoto; N Hashimoto; Y Ikada
Journal:  J Control Release       Date:  2000-02-14       Impact factor: 9.776

4.  Bone affinity of a bisphosphonate-conjugated protein in vivo.

Authors:  H Uludag; T Gao; G R Wohl; D Kantoci; R F Zernicke
Journal:  Biotechnol Prog       Date:  2000 Nov-Dec

5.  Effect of molecular weight of thermoreversible polymer on in vivo retention of rhBMP-2.

Authors:  T Gao; H Uludag
Journal:  J Biomed Mater Res       Date:  2001-10

6.  Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model.

Authors:  John Louis-Ugbo; Hak-Sun Kim; Scott D Boden; Matthew T Mayr; Ronald C Li; Howard Seeherman; Darren D'Augusta; Cara Blake; Aiping Jiao; Steve Peckham
Journal:  J Orthop Res       Date:  2002-09       Impact factor: 3.494

7.  Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.

Authors:  B H Woo; B F Fink; R Page; J A Schrier; Y W Jo; G Jiang; M DeLuca; H C Vasconez; P P DeLuca
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

Review 8.  In vivo mouse imaging and spectroscopy in drug discovery.

Authors:  Nicolau Beckmann; Rainer Kneuer; Hans-Ulrich Gremlich; Harry Karmouty-Quintana; François-Xavier Blé; Matthias Müller
Journal:  NMR Biomed       Date:  2007-05       Impact factor: 4.044

9.  Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.

Authors:  Diederik H R Kempen; Lichun Lu; Teresa E Hefferan; Laura B Creemers; Avudaiappan Maran; Kelly L Classic; Wouter J A Dhert; Michael J Yaszemski
Journal:  Biomaterials       Date:  2008-05-09       Impact factor: 12.479

10.  Release of recombinant human bone morphogenetic protein 2 from a newly developed carrier.

Authors:  S Yokota; T Uchida; S Kokubo; K Aoyama; S Fukushima; K Nozaki; T Takahashi; R Fujimoto; R Sonohara; M Yoshida; S Higuchi; S Yokohama; T Sonobe
Journal:  Int J Pharm       Date:  2003-01-30       Impact factor: 5.875

View more
  18 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

2.  Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects.

Authors:  A M Henslee; P P Spicer; D M Yoon; M B Nair; V V Meretoja; K E Witherel; J A Jansen; A G Mikos; F K Kasper
Journal:  Acta Biomater       Date:  2011-06-30       Impact factor: 8.947

Review 3.  Progress in three-dimensional printing with growth factors.

Authors:  Gerry L Koons; Antonios G Mikos
Journal:  J Control Release       Date:  2018-12-20       Impact factor: 9.776

Review 4.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

Review 5.  Imaging strategies for tissue engineering applications.

Authors:  Seung Yun Nam; Laura M Ricles; Laura J Suggs; Stanislav Y Emelianov
Journal:  Tissue Eng Part B Rev       Date:  2014-08-19       Impact factor: 6.389

6.  Effects of composite formulation on the mechanical properties of biodegradable poly(propylene fumarate)/bone fiber scaffolds.

Authors:  Xun Zhu; Nathan Liu; Michael J Yaszemski; Lichun Lu
Journal:  Int J Polym Sci       Date:  2010       Impact factor: 2.642

7.  Evaluation of bone regeneration using the rat critical size calvarial defect.

Authors:  Patrick P Spicer; James D Kretlow; Simon Young; John A Jansen; F Kurtis Kasper; Antonios G Mikos
Journal:  Nat Protoc       Date:  2012-09-27       Impact factor: 13.491

Review 8.  Pre-clinical characterization of tissue engineering constructs for bone and cartilage regeneration.

Authors:  Jordan E Trachtenberg; Tiffany N Vo; Antonios G Mikos
Journal:  Ann Biomed Eng       Date:  2014-10-16       Impact factor: 3.934

9.  Highly charged cyanine fluorophores for trafficking scaffold degradation.

Authors:  Eric A Owens; Hoon Hyun; Soon Hee Kim; Jeong Heon Lee; Gwangli Park; Yoshitomo Ashitate; Jungmun Choi; Gloria H Hong; Sergey Alyabyev; Sang Jin Lee; Gilson Khang; Maged Henary; Hak Soo Choi
Journal:  Biomed Mater       Date:  2013-01-25       Impact factor: 3.715

10.  Imaging challenges in biomaterials and tissue engineering.

Authors:  Alyssa A Appel; Mark A Anastasio; Jeffery C Larson; Eric M Brey
Journal:  Biomaterials       Date:  2013-06-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.